Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Cashew shell compound may help repair damaged nerves

In laboratory experiments, a chemical compound found in the shell of the cashew nut promotes the repair of myelin, a team from Vanderbilt University Medical Center reports today in the Proceedings of the National Academy of Sciences.

17 Aug 2020

Newly identified gene could improve treatment for multiple sclerosis

The disease multiple sclerosis (MS) attacks the central nervous system and, with time, can give rise to muscle tremors and loss of balance.

14 Aug 2020

Neil Bell appointed as Chief Development Officer of Avacta Life Sciences

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce the appointment of Neil Bell as Chief Development Officer of Avacta Life Sciences with immediate effect. Neil will be responsible for late stage pre-clinical and early clinical development of Avacta’s pipeline of pre|CISION pro-drugs and Affimer immunotherapies.

From Avacta Life Sciences Ltd. 13 Aug 2020

Reelin inhibition may be effective for treating multiple sclerosis

In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

12 Aug 2020

Study: Individuals who feel dizzy when they stand up may have an increased risk of dementia

Some people who feel dizzy or lightheaded when they stand up may have an increased risk of developing dementia years later, according to a new study published in Neurology®, the medical journal of the American Academy of Neurology.

7 Aug 2020

Climate change and disruption of ecosystem affect allergies, respiratory disorders

Climate change and disruption of the ecosystem have the potential to profoundly impact the human body. Xue Ming, professor of neurology at Rutgers New Jersey Medical School, who recently published a paper in the International Journal of Environmental Research and Public Health on the effects of climate change on allergies, autoimmunity and the microbiome -; the beneficial microorganisms that live on and inside the human body -; discusses how the delicate balance of the environment affects conditions such as allergies, autism, and immune disorders.

6 Aug 2020

Discovery of new mechanism in the immune system provides better understanding of diseases

An active immune system protects against diseases and infections. An overactive immune system is the body's worst enemy. One example of this is multiple sclerosis, which is a so-called autoimmune disease, while an overactive immune system also leads to some COVID-19 patients becoming seriously ill.

4 Aug 2020

Discovery could have important implications for brain infections, neurodegenerative diseases

More than 30 million Americans are infected with a brain parasite spread by cats and contaminated meat, but most will never show symptoms.

31 Jul 2020

Anti-inflammatory Tetracycline activity may modulate COVID-19 severity

The current COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), seems to attack the human airway epithelium primarily. In severely affected patients, the illness progresses to hypoxemic respiratory failure and acute respiratory distress syndrome (ARDS). The latter is treatable mainly by supportive management.

30 Jul 2020

Study reveals neural mechanisms underlying state mental fatigue in multiple sclerosis

Researchers at Kessler Foundation conducted a pilot study comparing the effects of mental fatigue on brain activation patterns in people with and without multiple sclerosis (MS).

28 Jul 2020

Human genome may explain the neonatal origins of chronic immune and inflammatory diseases

A study published in the journal Nature Communications has pinpointed a number of areas of the human genome that may help explain the neonatal origins of chronic immune and inflammatory diseases of later life, including type 1 diabetes, rheumatoid arthritis and coeliac disease.

28 Jul 2020

Study uncovers dual role for molecule involved in autoimmune eye disease

The inflammatory molecule interleukin-17A (IL-17A) triggers immune cells that in turn reduce IL-17A's pro-inflammatory activity, according to a study by National Eye Institute researchers.

23 Jul 2020

White blood cells and their role in the brain

Researchers have found that the brain has specific immune cells that help in normal brain development and play a role in certain neurological diseases.

23 Jul 2020

Study points to an important role for white blood cells in brain development

Whether white blood cells can be found in the brain has been controversial, and what they might be doing used to be complete mystery.

22 Jul 2020

Using AI to pinpoint neurons involved in gait reacquisition

Researchers at EPFL are able to get paralyzed rodents walking again by stimulating the animals' damaged spinal cords.

20 Jul 2020

Yale researchers uncover potential treatment for lethal Wolfram Syndrome

Yale pharmacology professor Barbara Ehrlich and her team have uncovered a mechanism driving a rare, lethal disease called Wolfram Syndrome and also a potential treatment. Their findings appear in the July 6 edition of Proceedings of the National Academy of Sciences.

16 Jul 2020

2021 health plans granted leeway to limit consumers’ benefit from drug coupons

Without medication to manage her plaque psoriasis, Jennifer Brown's face, scalp, trunk and neck periodically become covered in painful red, flaky patches so dry they crack and bleed.

6 Jul 2020

Researchers develop a potential treatment approach for Pelizaeus-Merzbacher disease

A team led by Case Western Reserve University medical researchers has developed a potential treatment method for Pelizaeus-Merzbacher disease (PMD), a fatal neurological disorder that produces severe movement, motor and cognitive dysfunction in children.

1 Jul 2020

Novel brain pathology could improve diagnosis, treatment of neurodegenerative diseases

Bristol scientists have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington's disease.

30 Jun 2020

SAFB1 may be a diagnostic marker for neurodegenerative diseases, shows study

Bristol scientists have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington's disease.

30 Jun 2020

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Cashew shell compound may help repair damaged nerves

Newly identified gene could improve treatment for multiple sclerosis

Neil Bell appointed as Chief Development Officer of Avacta Life Sciences

Reelin inhibition may be effective for treating multiple sclerosis

Study: Individuals who feel dizzy when they stand up may have an increased risk of dementia

Climate change and disruption of ecosystem affect allergies, respiratory disorders

Discovery of new mechanism in the immune system provides better understanding of diseases

Discovery could have important implications for brain infections, neurodegenerative diseases

Anti-inflammatory Tetracycline activity may modulate COVID-19 severity

Study reveals neural mechanisms underlying state mental fatigue in multiple sclerosis

Human genome may explain the neonatal origins of chronic immune and inflammatory diseases

Study uncovers dual role for molecule involved in autoimmune eye disease

White blood cells and their role in the brain

Study points to an important role for white blood cells in brain development

Using AI to pinpoint neurons involved in gait reacquisition

Yale researchers uncover potential treatment for lethal Wolfram Syndrome

2021 health plans granted leeway to limit consumers’ benefit from drug coupons

Researchers develop a potential treatment approach for Pelizaeus-Merzbacher disease

Novel brain pathology could improve diagnosis, treatment of neurodegenerative diseases

SAFB1 may be a diagnostic marker for neurodegenerative diseases, shows study

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in